February 08, 2023
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
International Diplomacy International Diplomacy
top
International Diplomacy
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
Menu
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
loading...
Latest Articles
  • Russian propaganda is more convincing than we think.
  • The presence of Saudi women expands in the “diplomatic corps”.
  • Biden signs a $1.66 trillion government funding bill
  • ISLAM & THE WEST (1-2) THE RELATIONS AND THE DIALOUGE
  • Biden requiring federal workers to prove Covid vaccine status or submit to strict safety rules
  • Microsoft posts big earnings beat, but Windows revenue from device makers falls 3%
  • After being ravaged by the delta Covid variant, how is India doing now?
  • ‘This feels like 1999’: Global start-up funding frenzy fuels fears of a bubble
  • Most fully vaccinated people who get Covid delta infections are asymptomatic, WHO says
  • Biden presses Putin to disrupt cybercriminals in Russia as U.S. grapples with latest ransomware attacks
Home AstraZeneca
AstraZeneca: Analysts point to promising pipeline despite Covid vaccine jitters

AstraZeneca: Analysts point to promising pipeline despite Covid vaccine jitters

Posted By: Editorial Teamon: April 09, 2021In: NEWSNo Comments

Controversy over AstraZeneca’s Covid-19 vaccine has sparked some investor concerns about its stock, according to Jefferies – but it’s not all bad news for the British pharmaceutical company. Australia, the Philippines and the African Union have become the latest to either curb or abandon planned purchases of the Oxford University-AstraZeneca coronavirus shot due to possible links to […] Read more

Share 0
Tweet
Share
Share
Share
Officials rush to defend AstraZeneca Covid vaccine after UK, EU blood clot guidance

Officials rush to defend AstraZeneca Covid vaccine after UK, EU blood clot guidance

Posted By: Editorial Teamon: April 08, 2021In: NEWSNo Comments

The British government and health experts in the country have rushed to defend the coronavirus vaccine developed by AstraZeneca and the University of Oxford following concerns over a possible link to blood clots. On Wednesday, the U.K.’s health and vaccine regulators issued a change of guidance over who should receive the shot. They now recommend that […] Read more

Share 0
Tweet
Share
Share
Share
EU medicines regulator finds possible link between AstraZeneca Covid vaccine and blood clots

EU medicines regulator finds possible link between AstraZeneca Covid vaccine and blood clots

Posted By: Editorial Teamon: April 07, 2021In: NEWSNo Comments

Europe’s medicines regulator found a possible link between the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues — though it said the benefits of getting the shot still outweigh its risks. Unusual blood clotting with low blood platelets will be added as a “very rare” side effect to the vaccine’s […] Read more

Share 0
Tweet
Share
Share
Share

Advertising

services
solutions
vrp

2018 Powered By GroupW

  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES